Diversion of opioid maintenance treatment medications and predictors for diversion among Finnish maintenance treatment patients
- 1 September 2015
- journal article
- research article
- Published by Elsevier in International Journal of Drug Policy
- Vol. 26 (9) , 875-882
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Illicit Use of Buprenorphine/Naloxone Among Injecting and Noninjecting Opioid UsersJournal of Addiction Medicine, 2011
- The Global Diversion of Pharmaceutical DrugsAddiction, 2010
- Abuse liability of intravenous buprenorphine/naloxone and buprenorphine alone in buprenorphine‐maintained intravenous heroin abusersAddiction, 2010
- Lack of Reduction in Buprenorphine Injection After Introduction of Co-Formulated Buprenorphine/Naloxone to the Malaysian MarketThe American Journal of Drug and Alcohol Abuse, 2009
- Buprenorphine injection in Melbourne, Australia—an updateDrug and Alcohol Review, 2008
- Case Series of Buprenorphine Injectors in Kuala Lumpur, MalaysiaThe American Journal of Drug and Alcohol Abuse, 2008
- Use and misuse of buprenorphine in the management of opioid addictionJournal of Opioid Management, 2007
- Abuse liability of buprenorphine–naloxone tablets in untreated IV drug usersDrug and Alcohol Dependence, 2007
- French Field Experience with BuprenorphineThe American Journal on Addictions, 2004
- Self-report among injecting drug users: A reviewDrug and Alcohol Dependence, 1998